2016 annual report: strengthening partnerships and openness


Under the auspices of Marie Curie, the 2016 annual Report clearly affirms the desire to see Institut Curie engaged with its environment, working within a network and sharing its skills

Couv Rapport annuel

Since its founding, Institut Curie has by definition been a very open, engaged establishment. A leading international establishment for cancer research and treatment such as Institut Curie needs to interact with its environment in order to extend its reach, enhance the scientific and medical community and remain at the forefront of innovation and basic knowledge.The Curie model has always been one of an organization that is not only integrated but also engaged with the outside world. As President of Institut Curie, Professor Thierry Philip, says in his introduction: “our project can be summed up in one word:engagement.”

This national and international dimension has continued to grow. This annual report is mainly focused on the Institut Curie’s international dimension. Being engaged with the outside world is a way to achieve greater innovation. Based in France, Institut Curie is part of a rich environment in which it has developed numerous ties with universities, hospitals, institutions and manufacturers, both nationally and abroad. It thus honors the pioneering, humanist spirit of Marie Curie, and her engagement in the world.


MC21: Institut Curie’s stategic Plan

2015 marked the launch of the MC21 strategic plan for Marie Curie 21St century. This project is inspired by the model created by Marie Curie in 1909: gathering researchers and physicians together to bring new medications to patients as quickly as possible. And as President of Institut Curie, Professor Thierry Philip, says in his introduction

2016 saw the continued implementation of the MC21 institutional project. In terms of the medical-scientific program, studies were launched at the Cancer Immunotherapy Center, discussions on breast cancer continued with the international leader Martine Piccart, and our scientific advisory board validated ophthalmology and pediatrics projects, which have resulted in a proposal for a pediatric center based on the model of the Immunotherapy Center.


This annual Report also provides an opportunity to thank the support of our donors: In 2016, Institut Curie was supported by the generosity of 200,000 donors, 38 sponsorship partners and 120 acts of generosity in France, though this generosity naturally extends beyond its borders.